110 related articles for article (PubMed ID: 24552289)
1. Loss of FBXW7 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma.
Enkhbold C; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Ishikawa D; Shimada M
Hepatol Res; 2014 Dec; 44(14):E346-52. PubMed ID: 24552289
[TBL] [Abstract][Full Text] [Related]
2. Loss of Secreted Frizzled-Related Protein-1 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma.
Davaadorj M; Saito Y; Morine Y; Ikemoto T; Imura S; Takasu C; Yamada S; Hiroki T; Yoshikawa M; Shimada M
Eur J Surg Oncol; 2017 Feb; 43(2):344-350. PubMed ID: 28062160
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia inducible factor expression in intrahepatic cholangiocarcinoma.
Morine Y; Shimada M; Utsunomiya T; Imura S; Ikemoto T; Mori H; Hanaoka J; Kanamoto M; Iwahashi S; Miyake H
Hepatogastroenterology; 2011; 58(110-111):1439-44. PubMed ID: 21940327
[TBL] [Abstract][Full Text] [Related]
4. Role of histone deacetylase expression in intrahepatic cholangiocarcinoma.
Morine Y; Shimada M; Iwahashi S; Utsunomiya T; Imura S; Ikemoto T; Mori H; Hanaoka J; Miyake H
Surgery; 2012 Mar; 151(3):412-9. PubMed ID: 21982637
[TBL] [Abstract][Full Text] [Related]
5. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma.
Ohta S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Wada Y; Yamashita S; Bando Y; Shimada M
Anticancer Res; 2019 Nov; 39(11):6025-6033. PubMed ID: 31704828
[TBL] [Abstract][Full Text] [Related]
7. Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient.
Miyazaki K; Morine Y; Yamada S; Saito Y; Tokuda K; Okikawa S; Yamashita S; Oya T; Ikemoto T; Imura S; Hu H; Morioka H; Tsuneyama K; Shimada M
Int J Clin Oncol; 2021 Dec; 26(12):2265-2274. PubMed ID: 34596803
[TBL] [Abstract][Full Text] [Related]
8. Loss of Fbxw7 expression is a predictor of recurrence in colorectal liver metastasis.
Kawashita Y; Morine Y; Ikemoto T; Saito Y; Iwahashi S; Yamada S; Higashijima J; Imura S; Ogawa H; Yagi T; Shimada M
J Hepatobiliary Pancreat Sci; 2017 Oct; 24(10):576-583. PubMed ID: 28846828
[TBL] [Abstract][Full Text] [Related]
9. Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy.
Ishii N; Araki K; Yokobori T; Watanabe A; Tsukagoshi M; Kubo N; Suzuki H; Saito F; Altan B; Hosouchi Y; Shirabe K; Kuwano H
Oncol Lett; 2017 May; 13(5):3653-3661. PubMed ID: 28521468
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis.
Shirabe K; Shimada M; Tsujita E; Aishima S; Maehara S; Tanaka S; Takenaka K; Maehara Y
Am J Surg; 2004 Apr; 187(4):538-42. PubMed ID: 15041507
[TBL] [Abstract][Full Text] [Related]
11. Role of dihydropyrimidine dehydrogenase and thymidylate synthase expression in immunohistochemistry of intrahepatic cholangiocarcinoma.
Nishi M; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Hanaoka J; Bando Y
Hepatol Res; 2011 Jan; 41(1):64-70. PubMed ID: 20880064
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma.
Xia XL; Xue D; Xiang TH; Xu HY; Song DK; Cheng PG; Wang JQ
Oncol Lett; 2018 Apr; 15(4):4105-4112. PubMed ID: 29556285
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the combined expression of neutral endopeptidase and dipeptidyl peptidase IV in intrahepatic cholangiocarcinoma patients after surgery resection.
Zhu J; Guo X; Qiu B; Li Z; Xia N; Yang Y; Liu P
Onco Targets Ther; 2014; 7():297-304. PubMed ID: 24570591
[TBL] [Abstract][Full Text] [Related]
14. FBXW7 modulates malignant potential and cisplatin-induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1.
Mori A; Masuda K; Ohtsuka H; Shijo M; Ariake K; Fukase K; Sakata N; Mizuma M; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Fujishima F; Unno M
Cancer Sci; 2018 Dec; 109(12):3883-3895. PubMed ID: 30302867
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma.
Bunsiripaiboon P; Sornmayura P; Wilasrusmee C; Lertsithichai P
J Med Assoc Thai; 2010 Jan; 93(1):66-72. PubMed ID: 20196413
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-9 in surgically resected intrahepatic cholangiocarcinoma.
Shirabe K; Shimada M; Kajiyama K; Hasegawa H; Gion T; Ikeda Y; Takenaka K; Sugimachi K
Surgery; 1999 Nov; 126(5):842-6. PubMed ID: 10568183
[TBL] [Abstract][Full Text] [Related]
17. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker.
Ong KH; Hsieh YY; Sun DP; Huang SK; Tian YF; Chou CL; Shiue YL; Joseph K; Chang IW
Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443694
[TBL] [Abstract][Full Text] [Related]
18. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors predicting survival rate over 10 years of patients with intrahepatic cholangiocarcinoma after hepatic resection.
Ma CH; Hwang DW; Song KB; Kim SC; Shin SH; Lee JH
Ann Surg Treat Res; 2020 Mar; 98(3):116-123. PubMed ID: 32158731
[TBL] [Abstract][Full Text] [Related]
20. Role of heat shock factor 1 expression in the microenvironment of intrahepatic cholangiocarcinomas.
Kawashita Y; Morine Y; Saito Y; Takasu C; Ikemoto T; Iwahashi S; Teraoku H; Yoshikawa M; Imura S; Yagi T; Shimada M
J Gastroenterol Hepatol; 2018 Jul; 33(7):1407-1412. PubMed ID: 29278438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
